Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Coeur Commences Drilling at Silver North's Tim Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News QuidelOrtho Corp QDEL

Healthcare Medical Devices
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies... see more

Recent & Breaking News (NDAQ:QDEL)

Quidel and World Champion Los Angeles Rams Partner to Combat COVID-19 and Promote Health Awareness in the L.A. Community

Business Wire September 1, 2022

Bacterial Biofilms, Responsible for Up to 75% of All Infectious Diseases in America, Explored in New Webinar From Quidel Corporation

Business Wire August 24, 2022

QuidelOrtho Announces $300 Million Share Repurchase Authorization

Business Wire August 17, 2022

QuidelOrtho Reports Second Quarter 2022 Financial Results

Business Wire August 4, 2022

ORTHO RANKS NO. 1 IN CUSTOMER SATISFACTION FOR 5 YEARS IN A ROW

PR Newswire July 26, 2022

QuidelOrtho to Report Second Quarter 2022 Financial Results on August 4, 2022

GlobeNewswire July 18, 2022

Quidel Corporation and the American Heart Association join forces to Advance Education and Awareness of Heart Disease in San Diego County

Business Wire June 21, 2022

QUIDEL CORP.—DEVELOPER OF ONLY FDA-CLEARED FIA RAPID POINT-OF-CARE DIAGNOSTIC LYME DISEASE TEST—TO PARTNER WITH RENOWNED GLOBAL LYME ALLIANCE TO DRAMATICALLY HEIGHTEN LYME DISEASE AWARENESS

TheNewsWire June 9, 2022

Quidel Corp.-Developer of Only FDA-Cleared FIA Rapid Point-of-Care Diagnostic Lyme Disease Test-To Partner With Renowned Global Lyme Alliance to Dramatically Heighten Lyme Disease Awareness

Business Wire June 9, 2022

QuidelOrtho Formed by the Completion of Transaction Combining Quidel and Ortho Clinical Diagnostics

Business Wire May 27, 2022

Quidel and Ortho Announce Expected Closing of Ortho Transaction

Business Wire May 26, 2022

Ortho Clinical Diagnostics Shareholders Approve Quidel Transaction

GlobeNewswire May 16, 2022

Quidel Announces Stockholder Approval of Ortho Acquisition and Business Combination

Business Wire May 16, 2022

Quidel Reports First Quarter 2022 Financial Results

Business Wire May 4, 2022

Quidel to Hold Fiscal First Quarter 2022 Financial Results Conference Call on May 4th, 2022

Business Wire April 12, 2022

Quidel Announces Preliminary Revenue for First Quarter 2022

Business Wire April 7, 2022

Quidel to Present at Raymond James 43rd Annual Institutional Investors Conference

Business Wire February 28, 2022

Quidel Reports Fourth Quarter and Full Year 2021 Financial Results

Business Wire February 17, 2022

Quidel to Hold Fiscal Fourth Quarter and Full Year 2021 Financial Results Conference Call on February 17th, 2022

Business Wire February 1, 2022

Shareholder Alert: The M&A Class Action Firm Announces an Investigation of the Merger

PR Newswire January 10, 2022